Actinium Pharmaceuticals held its 2024 annual meeting where Sandesh Seth and Jeffrey W. Chell were re-elected as Class II directors for a three-year term, and Marcum LLP was ratified as the independent accounting firm for 2024, with 19,724,287 shares represented at the meeting.